Has Giancarlo Lugo received payments from drug or device companies?

Yes. Drug and device makers reported $9,940 in general payments to Giancarlo Lugo across 325 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Giancarlo Lugo did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Giancarlo Lugo come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Giancarlo Lugo

Neurology with Special Qualifications in Child Neurology · Madera, CANPI 1366881674

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,773 of the $9,940 with a category attached, or 88.3%. It is spread thinly across 43 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations.

$9,940in general payments, 2019–2025

Across 325 payments — averaging $30.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Livanova USA, Inc.$2K
UCB, Inc.$1K
Neurelis, Inc.$888
Catalyst Pharmaceuticals, Inc.$694
Jazz Pharmaceuticals Inc.$683
PTC Therapeutics, Inc.$389
plus $4K from 37 others

What the payments were for

Travel & lodging$1,16712%
Food & beverage$8,77388%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Livanova USA, Inc.	23	$2,174
UCB, Inc.	44	$1,123
Neurelis, Inc.	33	$888
Catalyst Pharmaceuticals, Inc.	29	$694
Jazz Pharmaceuticals Inc.	22	$683
PTC Therapeutics, Inc.	20	$389
Biogen	12	$296
Aucta Pharmaceuticals, Inc.	10	$248
NS Pharma, Inc.	11	$240
Zogenix Inc.	7	$223
Supernus Pharmaceuticals, Inc.	5	$216
Ipsen Biopharmaceuticals, Inc	8	$216
Sumitomo Pharma America, Inc.	12	$198
Genentech USA, Inc.	8	$196
AstraZeneca(2 entities)	9	$195
Genentech, Inc.	1	$139
Monteris Medical Corporation	1	$137
Mallinckrodt Enterprises LLC	1	$135
ITF Therapeutics LLC	6	$132
Immedica Pharma US, Inc.	4	$122
SK Life Science, Inc.	5	$117
Acadia Pharmaceuticals Inc	4	$107
Argenx US, Inc.	4	$104
Sunovion Pharmaceuticals Inc.	7	$103
Eisai Inc.	5	$102
Greenwich Biosciences, Inc.	3	$79
Aquestive Therapeutics, Inc.	4	$68
Neuropace, Inc.	3	$66
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)	3	$60
AbbVie(2 entities)	2	$57
Amneal Pharmaceuticals LLC	2	$57
Azurity Pharmaceuticals, Inc.	2	$54
Biocodex, Inc.	2	$51
Piramal Critical Care	2	$44
Nobelpharma America, LLC	2	$40
Ultragenyx Pharmaceutical Inc.	2	$37
Sarepta Therapeutics, Inc.	1	$29
Ironshore Pharmaceuticals Inc.	1	$25
Travere Therapeutics, Inc.	1	$22
Novartis	1	$21
Upsher-smith Laboratories LLC	1	$20
Cranial Technologies, Inc	1	$17
Biomarin Pharmaceutical Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VNS Therapy$1,597
Epidiolex$142
EVRYSDI$139
Neuroblate$137
ACTHAR$135
VNS - Sentiva$125
Briviact$125
QELBREE$125
Fintepla$124
VALTOCO$124
VNS THERAPY SENTIVA MODEL 1000 GENERATOR$109

How this compares

$9,940 in reported general payments places this provider in the 80th percentile of 216 neurology with special qualifications in child neurology providers in California.

See all neurology with special qualifications in child neurology providers in California →

Other neurology with special qualifications in child neurology in Madera

Kevin ShapiroMadera$84K
Raymund DavidMadera$31K
Cesar SantosMadera$16K
Merveen AppuMadera$12K
Milagros Silva-ColonMadera$8K
Michael ChezSacramento$374K
Allen BottOakland$372K
Joseph SullivanSan Francisco$240K
Ann SegerenStanford$172K
Rajsekar RajaramanLos Angeles$134K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →